Today’s stock pick update – Open Now

[Learn More]( [3 Stocks Going Up In Price Tomorrow]( Find winning trades in minutes with our patent pending software! Get bullish & bearish stock & options picks with exact entry/exit points for each trading day!(Ad) [Find out more…]( Moderna Shares Surge After Early Trial Shows Its Coronavirus Vaccine Candidate Generates A “Robust” Immune Response [Goldman Sachs]( shares gained nearly 5% at the open after the bank reported blow-out earnings results. Goldman posted $2.42 billion in profit, or $6.26 per share, crushing analysts’ estimates for $3.78 per share. Revenue came in more than $3.5 billion higher than estimates at $13.3 billion—the second highest revenue ever reported for the firm—on strong results in the bank’s trading and investme... [Read More]( XBiotech (NASDAQ: [XBIT]( XBiotech shares got a boost yesterday after the company announced a discovery that its drug candidate antibody that blocks interleukin-1 alpha can be used as a therapeutic to reduce brain damage and neurological deficit after stroke. The drug candidate was researched by the team of Dr. Giovanni Camici, Director for the Center for Molecular Cardiology at the... [Read More]( [Is ADM a smart defensive buy?]( In the meantime, there are plenty of other questions about other economic elements that should be cause for concern. The real effect of lapsing, federally-funded PPP money and extended unemployment benefits this month remains to be seen, but should naturally expect to be taken as a headwind for consumer strength and confidence. [Read More]( Featured Stock [GenMark Diagnostics, Inc. (GNMK) – Buy Price: $18.50 or better]( GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. [Read More]( Other Top Stories - [Fed survey says economy has picked up but outlook cloudy]( - [Fed survey finds economic activity increased in almost all regions but still remains well below pre-pandemic levels]( - [Casper Star-Tribune to cease Monday, Tuesday print editions]( - [Microsoft cuts MSN news staffers in move toward AI editors]( - ['We don't want them,' Mallorca says of wild-wayed tourists]( Trend Following Picks - [GenMark Diagnostics, Inc. (GNMK) – Buy Price: $18.50 or better]( - [Sintx Technologies, Inc. (SINT) – Buy Price: $2.10 or better]( - [TG Therapeutics, Inc. (TGTX) – Buy Target: $24.50 or better]( - [Osmotica Pharmaceuticals plc (OSMT) -Buy Price: $8.00 or better]( - [Edison Nation, Inc. (EDNT) – Buy Price: $3.60 or better]( [All Picks]( Reversal Picks - [Trio-Tech International (TRT) Buy Target $3.13 Sell Target $3.27]( - [Independence Contract Drilling, Inc. (ICD) Buy Target $3.84 Sell Target $4.48]( - [Arlington Asset Investment Corp. (AI) Buy Target $3.06 Sell Target $3.29]( - [Moxian, Inc. (MOXC) Buy Target $1.46 Sell Target $1.89]( - [GAIN Capital Holdings, Inc. (GCAP) Buy Target $6.27 Sell Target $6.44]( [All Picks]( Low Price Stock Picks - [Baytex Energy Corp. (BTE)]( - [Texas Mineral Resources Corp. (TMRC)]( - [Hill International, Inc. (HIL)]( - [Senseonics Holdings, Inc. (SENS)]( - [Denbury Resources Inc. (DNR)]( [All Picks]( Already subscribed to our premium service? [Click here to Login.]( Not a TradersPro subscriber yet? [Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits]( --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019